PALO ALTO, Calif. and
BEIJING, Sept. 11, 2019 /PRNewswire/ -- Varian (NYSE:
VAR) has received notice from the Customs Tariff Commission of the
State Council of China that
medical linear accelerators are excluded from the additional
tariffs China imposed on US
products that began on August 23,
2018. The exclusion is retroactive, and the company expects
to be eligible for a refund from tariffs that have been levied
since the additional tariffs were implemented. The exemption will
become effective on September 17,
2019.
"We are grateful for the China
government's determination to fight cancer and its recognition of
the positive impact of radiotherapy treatments," said Dow Wilson,
president and chief executive officer, Varian. "Varian envisions a
world without fear of cancer, and we are committed to empowering
our users to achieve new victories against cancer with our cancer
care solutions. The exemption allows us to continue to focus on the
fight against cancer."
Varian is in its quiet period but will evaluate if further
comments are necessary after completing its assessment of the
impact of this exclusion, including the timing and process for any
refunds. The company's fiscal year 2019 earnings conference
call is scheduled for Wednesday, October 23,
2019 at 1:30pm Pacific
Time.
About Varian
At Varian (NYSE: VAR), we envision a
world without fear of cancer. For more than 70 years, we have
developed, built and delivered innovative cancer care technologies
and solutions for our clinical partners around the globe to help
them treat millions of patients each year. With an Intelligent
Cancer Care approach, we are harnessing advanced technologies like
artificial intelligence, machine learning and data analytics to
enhance cancer treatment and expand access to care. Our 9,200
employees across 70 countries keep the patient and our clinical
partners at the center of our thinking as we power new victories in
cancer care. Because, for cancer patients everywhere, their fight
is our fight. For more information, visit http://www.varian.com and
follow @VarianMedSys on Twitter.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Helen Yang
Manager, Greater China Public Relations
+86 (10) 87836354
helen.yang@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-expects-to-benefit-from-linear-accelerator-tariff-exclusion-in-china-300916472.html
SOURCE Varian